z-logo
open-access-imgOpen Access
SỰ PHÙ HỢP TRONG SỬ DỤNG THUỐC ĐIỀU TRỊ BỆNH TAY CHÂN MIỆNG
Author(s) -
Bùi Đặng Lan Hương,
Bùi Đặng Phương,
Trần Thị Kiều Trinh
Publication year - 2021
Publication title -
y học cộng đồng
Language(s) - English
Resource type - Journals
ISSN - 2354-0613
DOI - 10.52163/jcm.v62i2.49
Subject(s) - midazolam , medicine , diazepam , cefuroxime , antibiotics , pediatrics , anesthesia , chemistry , biochemistry , sedation
Objective: To evaluate the appropriateness in using drugs of hand, foot and mouth disease treatment at the Children’s Hospital of Can Tho city in 2019. Subjects and methods: Retrospective cross-sectional descriptive study on 400 medical records of inpatients at Can Tho Children’s Hospital during the period from January 2019 to December 2019. Results: There was a statistically significant difference between the group of patients using the dose appropriate to the prescribed dose (P = 0.000 <0.005). Drugs with the most suitable delivery rhythm were Paracetamol, Midazolam, Diazepam, Adrenalin, Dobutamim, Immunoglobulin G, Cefuroxim with 100% as recommended. The lowest rate of used drugs compared to the recommendations was Cefotaxim (89.9%) and Ceftriaxon (83.3%). The most used oral medications: Paracetamol, Ibuprofen, Phenobarbital, Chlorpheniramine, Diazepam, Adrenalin, Dobutamim, Immunoglobulin G were suitable to the 100% recommendation. The lowest appropriate rate compared with the recommendation was Cefuroxime, which accounted for 6.7%, using the injection route in accordance with the recommendation. The more common pair of interactions was Paracetamol and Phenobabital concomitantly accounted for 90.6% of the total 149 of the recorded interactions and a lower proportion was the pair of Midazolam with Phenobabital, accounting for 9.4%. Conclusion: Most drugs with highly suitable indications for use, of which the highest were Paracetamol, Diazepam, Adrenalin, Dobutamim, Immunoglobulin G. Antibiotics had the lowest appropriate utilization rate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here